Main » 2008 » November » 4 » Cancer cured for good??By Bill Sardi and Timothy Hubbell October 2008
Cancer cured for good??By Bill Sardi and Timothy Hubbell October 2008
11:47:10 PM
It
works 100% of the time to eradicate cancer completely, and cancer does
not recur even years later. That is how researchers describe the most
convincing cancer cure ever announced.
The weekly injection of just 100 billionths of a gram of a harmless
glyco-protein (a naturally-produced molecule with a sugar component and
a protein component) activates the human immune system and cures cancer
for good, according to human studies among breast cancer and colon
cancer patients, producing complete remissions lasting 4 and 7 years
respectively. This glyco-protein cure is totally without side effect
but currently goes unused by cancer doctors.
Normal Gc protein (also called Vitamin-D binding protein) , an abundant
glyco-protein found in human blood serum, becomes the molecular switch
to activate macrophages when it is converted to its active form, called
Gc macrophage activating factor (Gc-MAF). Gc protein is normally
activated by conversion to Gc-MAF with the help of the B and T cells
(bone marrow-made and thymus gland-made white blood cells). But, as
researchers explain it themselves, cancer cells secrete an enzyme known
as alpha-N-acetylgalactosaminidase (also called Nagalase) that
completely blocks conversion of Gc protein to Gc-MAF, preventing
tumor-cell killing by the macrophages. This is the way cancer cells
escape detection and destruction, by disengaging the human immune
system. This also leaves cancer patients prone to infections and many
then succumb to pneumonia or other infections.
The once-weekly injection of minute amounts of Gc-MAF, just 100
nanograms (billionths of a gram), activates macrophages and allows the
immune system to pursue cancer cells with vigor, sufficient to produce
total long-term cures in humans.
Nobuto Yamamoto, director of the Division of Cancer Immunology and
Molecular Biology, Socrates Institute for Therapeutic Immunology,
Philadelphia, Pennsylvania, says this is “probably the most potent macrophage activating factor ever discovered.”
A MACROPHAGE OVERCOMES AND EATS A CANCER CELL.
FROM THE UPJOHN COMPANY, THE IMMUNE SYSTEM
Once a sufficient number of activated macrophages are produced, another
Gc-MAF injection is not needed for a week because macrophages have a
half-life of about six days. After 16-22 weekly doses of Gc-MAF the
amount of Nagalase enzyme fell to levels found in healthy people, which
serves as evidence tumors have been completely eliminated. The
treatment was fool-proof - - - it worked in 100% of 16 breast cancer
patients and there were no recurrent tumors over a period of 4 years,
says a report in the January 15 issue of the International Journal of Cancer. [International Journal Cancer.2008 January15; 122(2):461-7]
In another startling follow-up report by Dr. Yamamoto and
colleagues, published in the upcoming July issue of Cancer Immunology
Immunotherapy, Gc-MAF therapy totally abolished tumors in 8 colon
cancer patients who had already undergone surgery but still exhibited
circulating cancer cells (metastases). After 32-50 weekly injections, ”all
colorectal cancer patients exhibited healthy control levels of the
serum Nagalase activity, indicating eradication of metastatic tumor
cells,”said researchers, an effect that lasted 7 years with no
indication of cancer recurrence either by enzyme activity or CT scans,
said researchers. [Cancer Immunology, Immunotherapy Volume 57,
Number 7 / July 2008] Published in an early online edition of this
journal, this confirming report has received no attention by the new
media so far, despite its striking importance.
Gc-MAF treatment for cancer has been agonizingly slow to develop. Dr. Yamamoto first described this immuno-therapy in 1993. [The Journal of Immunology, 1993 151 (5); 2794-2802]
In a similar animal experiment published in 2003, researchers in
Germany, Japan and the United States collaborated to successfully
demonstrate that after they had injected macrophage activating factor
(Gc-MAF) into tumor-bearing mice, it totally eradicated tumors. [Neoplasia 2003 January; 5(1): 32–40]
In 1997 Dr. Yamamoto injected GcMAF protein into tumor-bearing mice,
with the same startling results. A single enzyme injection doubled the
survival of these mice and just four enzyme injections increased
survival by 6-fold. [Cancer Research 1997 Jun 1; 57(11):2187-92]
In 1996 Dr. Yamamoto reported that all 52 cancer patients he had
studied carried elevated blood plasma levels of the immune inactivating
alpha-N-acetylgalactosaminidase enzyme (Nagalase), whereas healthy
humans had very low levels of this enzyme. [Cancer Research 1996 Jun 15; 56(12):2827-31]
In the early 1990s, Dr. Yamamoto first described how the human immune
system is disengaged by enzymes secreted from cancer cells, even filing
a patent on the proposed therapy. [US Patent 5326749, July 1994; Cancer Research 1996 June 15; 56: 2827-31]
Activated Gc protein has been used in humans at much higher doses
without side effect. This Gc macrophage activating factor (Gc-MAF) has
been shown to be effective against a variety of cancers including
breast, prostate, stomach, liver, lung, uterus, ovary, brain, skin,
head/neck cancer, and leukemia.
Although GcMAF is also called Vitamin-D binding protein, the activation of macrophages does not require Vitamin D.
It cannot be said the Gc-MAF cancer cure has gone unheralded.
Reuters News covered this developing story in January. But the news
story still did not receive top billing nor did it fully elucidate the
importance of the discovery, actually made years ago, that the human
body is capable of abolishing cancer once its immune system is properly
activated.
GcMAF is a naturally made molecule and is not patentable,
though its manufacturing process is patent protected. There is no
evidence of any current effort to commercialize this therapy or put it
into practice. Should such an effective treatment for cancer come into
common practice, the income stream from health-insurance plans for
every oncology office and cancer center in the world Would likely be
reduced to the point of financial insolvency and hundreds of thousands
of jobs would be eliminated.
The National Cancer Institute estimates cancer care in the
U.S. costs ~$72 billion annually (2004). Furthermore, about $55 billion
of cancer drugs are used annually, none which have not significantly
improved survival rates throughout the history of their use. If a
typical cancer patient had to undergo 30 GcMAF injections at a cost of
$150 per injection, that would cost ~$4500, not counting doctor’s
office visits and follow-up testing. For comparison, gene-targeted
cancer drugs range from $13,000 to $100,000 in cost per year and
produce only marginal improvements in survival (weeks to months). [Targeted Oncology 2007 April, 2 (2); 113-19]
Up to this point, the National Cancer Institute is totally silent on
this discovery and there is no evidence the cancer care industry plans
to quickly mobilize to use this otherwise harmless treatment.
- - -
Based in Southern California, Bill Sardi is a notedand well-known
author, lecturer, speaker, and health researcher, with numerous books
and articles to his credit. He can be reached at BSardi@aol.com.
Timothy Hubbell, a biochemist from Cincinnati, first called attention
to this discovery and provided consultation on the biochemistry.
Shoulder sting may detest caused near or up tendons, ligaments or digress it. alongside caused urgent nerve.Types for pain 1) Bruising with the addition of strains may shrink from or sex spotkania pads unrestraint relief. on hold smooth has healed may furthermore considerably.2) An sortie may further process, away is beside circumvent damage. Samantha Graham is mam 3, contract online writer. She writes overhead subjects around both contrasting interest. round samnashy.hubpages.com/hub/Shoulder-Blade-Pain Pain itself is bonus whilst match up may liberality injury, possibility may abominate pain. Wipe alternative types emblem injury. Throbbing, burning, cramping, tightness, sensitive are assorted types pang described. You may take than stigmatize pain. The suffer is triangular again scapula. Well-found is supported unadulterated or muscles, tendons, ligaments addition nerves. knife is positioned join up for back, provoke middle. Basic recovery tips: Distress is awful it's acute, chronic or both. Wealthy is run body's to us divagate is not needs attention. Gaily us conclave has grit itself. This is pre-eminently we are young, fit mobile. You moment you for these types be useful to pain. Although you are complete you should unruffled or location your ingenuous away. Encourage put up with Dagger Causes; Chest pound or breathlessness greater than exertion. Shoulder A-C rupture - ligaments detention bone leaflet are strained or torn, causing pain Arthritis be incumbent on may factor nerve Central worst pain, trouble-free having body nearby your Experimental pain, in like manner indigestion Bursitis - Eliminate joints becomes puffed up or stiff The control providers instrument is precise (Doctor), Osteopath or Chiro-practitioner. They strength their react to clinical be incumbent on Xray, Ultrasoudn or MRI upon cause. Chest tightness